Fresenius Kabi
Fresenius Kabi is a global healthcare company dedicated to life, with a mission to improve treatment and therapies for patients in need of care. They focus on innovation, quality, and reliability across their extensive portfolio in pharmaceuticals, clinical nutrition, medical technologies, and biopharmaceuticals. With a presence in over 100 countries and around 41,000 employees, they support healthcare professionals worldwide to enhance patient care and access to high-quality healthcare.
Industries
Nr. of Employees
Very Large (1000+)
Fresenius Kabi
Av. Cabildo 2677, Piso 10, Ciudad Autónoma de Buenos Aires, Argentina
Patents
Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
US-11883532-B2
View DetailsPlunger rod comprising at least three annular elements for a prefilled syringe
US-11571520-B2
View DetailsPlunger rod comprising at least three annular elements for a prefilled syringe
US-10543319-B2
View Details
Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
US-11883532-B2
View DetailsPlunger rod comprising at least three annular elements for a prefilled syringe
US-11571520-B2
View DetailsPlunger rod comprising at least three annular elements for a prefilled syringe
US-10543319-B2
View DetailsProducts
Enteral nutrition portfolio (oral supplements, tube feeds, powders)
Range of enteral nutrition products including ready-to-drink formulas, oral nutritional supplements, tube-feeding formulas and powdered nutrition products for clinical indications.
Parenteral nutrition solutions and multi-chamber bags
Parenteral nutrition products including amino acid solutions, lipid emulsions, carbohydrate components and multi‑compartment bags for intravenous nutrition therapy.
Infusion systems and modular infusion pumps
Infusion systems comprising modular pumps and central displays designed to present relevant clinical information and support flexible deployment in critical care and ward settings.
Infusion tubing and volumetric application systems
Infusion lines and tubing systems engineered for pump-assisted volumetric infusion to ensure dosing accuracy and constant infusion rates.
Blood collection and processing bag systems
Single- to multi-bag blood collection and processing systems available in multiple sizes and configurations to support separation and preparation of blood components.
Biosimilar monoclonal antibody products (denosumab class example)
Development and commercialization of monoclonal antibody biosimilars targeting therapeutic indications of reference biologics, with regulatory filings submitted to major authorities.
Enteral nutrition portfolio (oral supplements, tube feeds, powders)
Range of enteral nutrition products including ready-to-drink formulas, oral nutritional supplements, tube-feeding formulas and powdered nutrition products for clinical indications.
Parenteral nutrition solutions and multi-chamber bags
Parenteral nutrition products including amino acid solutions, lipid emulsions, carbohydrate components and multi‑compartment bags for intravenous nutrition therapy.
Infusion systems and modular infusion pumps
Infusion systems comprising modular pumps and central displays designed to present relevant clinical information and support flexible deployment in critical care and ward settings.
Infusion tubing and volumetric application systems
Infusion lines and tubing systems engineered for pump-assisted volumetric infusion to ensure dosing accuracy and constant infusion rates.
Blood collection and processing bag systems
Single- to multi-bag blood collection and processing systems available in multiple sizes and configurations to support separation and preparation of blood components.
Biosimilar monoclonal antibody products (denosumab class example)
Development and commercialization of monoclonal antibody biosimilars targeting therapeutic indications of reference biologics, with regulatory filings submitted to major authorities.
Services
Coordination of discharge and outpatient/home administration for patients requiring enteral or parenteral nutrition, including training, logistics and patient support.
Manufacturing services including sterile filling, finishing, packaging and tailored line changeovers for third parties and internal products.
End-to-end R&D support including formulation development, feasibility, pilot studies, process scale-up and analytical method development/validation.
High-capacity packaging and distribution services with automated warehousing and multiple temperature zones for secure national and international supply chains.
Continued education programs, e-learning modules and multimedia educational content on product use, clinical management and best practices.
Coordination of discharge and outpatient/home administration for patients requiring enteral or parenteral nutrition, including training, logistics and patient support.
Manufacturing services including sterile filling, finishing, packaging and tailored line changeovers for third parties and internal products.
End-to-end R&D support including formulation development, feasibility, pilot studies, process scale-up and analytical method development/validation.
High-capacity packaging and distribution services with automated warehousing and multiple temperature zones for secure national and international supply chains.
Continued education programs, e-learning modules and multimedia educational content on product use, clinical management and best practices.
Expertise Areas
- Clinical nutrition (enteral and parenteral)
- Biopharmaceuticals and biosimilars development
- Sterile and aseptic manufacturing
- MedTech infusion systems and infusion safety
Key Technologies
- Aseptic filling and sterile processing
- Lyophilization (freeze-drying)
- Multi-chamber parenteral nutrition bags
- Infusion pump systems and user-interface design
News & Updates
Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilars Conexxence® (denosumab-bnht) and Bomyntra® (denosumab-bnht) of its operating company Fresenius Kabi has been approved by the FDA.
Fresenius Kabi is a Top Employer in 2025, with twelve countries receiving certification from the Top Employers Institute.
Discover how Woodrow Elam brings calm, clarity and care to his role as Packaging Operator in Wilson, NC. He helps ensure quality for patients around the world.
Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilars Conexxence® (denosumab-bnht) and Bomyntra® (denosumab-bnht) of its operating company Fresenius Kabi has been approved by the FDA.
Fresenius Kabi is a Top Employer in 2025, with twelve countries receiving certification from the Top Employers Institute.
Discover how Woodrow Elam brings calm, clarity and care to his role as Packaging Operator in Wilson, NC. He helps ensure quality for patients around the world.